This interview will be broadcast during the live edition of Die GROOT Ontbyt on Wednesday morning, 4 December 2024. It has been a few years since South Africans were advised by the Department of Health to receive the COVID vaccinations. Questions still arise about the research, effectiveness, and side effects among many South Africans. To […]
Johannesburg, South Africa – 18 August 2024 Click here to download PDF of this press release We are deeply concerned about the recent announcements made by Africa CDC Director General Jean Kaseya on 13 August 2024 and WHO Director-General Tedros Adhanom Ghebreyesus on 14 August 2024. It is important to address these announcements openly to
The document discusses the distribution of COVID 19 deaths among different age groups and vaccination statuses as of August 15, 2021. Key points include: In the UK, 68% of COVID 19 patients over age 50 admitted to hospitals had received one or two vaccine doses. 70% of COVID 19 deaths in the over 50 age
This Israeli study compares natural immunity to vaccine induced immunity against the Delta variant of SARS CoV 2. Analysing data from Maccabi Healthcare Services, it found that previously infected individuals had significantly lower risks of reinfection and symptomatic COVID 19 than those who were only vaccinated. Vaccinated individuals were 13.06 times more likely to have
As many as 80% of South Africans may have contracted COVID 19, according to Discovery’s chief actuary, Emile Stipp. His estimates are based on the country’s case fatality rate and excess deaths, which provide a more accurate impact of the pandemic than the official toll. Stipp suggests that South Africa’s infection rate, estimated between 70%
The meta analysis and systematic review assess age specific infection fatality rates (IFRs) for COVID 19, revealing a clear exponential increase in IFR with age. The analysis, which included 113 studies and 34 locations, found that IFR is extremely low for young people but rises significantly with age, reaching 15% for those aged 85. The
The document by Hervé Seligmann evaluates the effects of the Pfizer COVID 19 vaccine. It raises concerns about potential adverse effects and the adequacy of clinical trial data. The analysis suggests that there may be underreporting of negative outcomes and emphasises the importance of comprehensive post vaccination monitoring to ensure safety and efficacy. The report
The document discusses the spread of COVID 19 among vaccinated individuals in highly vaccinated countries, highlighting data from the UK, Israel, Chile, Seychelles, and Mongolia. It reports significant numbers of new symptomatic COVID 19 cases among the vaccinated, with the vaccinated populations in these countries experiencing higher or comparable infection rates to the unvaccinated. The
Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.